By
AmyT on
December 2, 2011
Yesterday marks “a milestone” in the development of new technology to help automate the care and treatment of type 1 diabetes, according to JDRF!
The U.S. Food and Drug Administration unveiled its eagerly awaited Draft Guidance document for research and development of the Artificial Pancreas system, and initial reaction from JDRF — in a press conference held yesterday afternoon — was a mix of jubilation and a more measured response that they remain “guardedly optimistic” about the details…
Read more »
By
AmyT on
February 28, 2011
Recently I stumbled upon a firm based in Fort Lauderdale, FL, that calls itself Pancreum, “The Wearable Artificial Pancreas Company.” Wow. Really? There is such a thing already? I just had to investigate.
The company’s website describes a four-part system including a controller (PDA), a CGM sensor called the “GlucoWedge,” a small wireless insulin pump called the “BetaWedge,” a small wireless glucagon pump called the “AlphaWedge,” and a set of “iPancreum” software apps that manage…
Read more »
As reported yesterday, the JDRF Capitol Chapter hosted their first annual research summit in Bethesda, MD, on Saturday. Just days before, the staff reported that they were expecting more than 400 people. Not bad! The line-up included talks on the rise of type 1 diabetes, preventing type 1, the latest in artificial pancreas technology, and why human studies are crucial for the next steps in research.
I sat alongside several other D-bloggers, including Scott Strumello,…
Read more »
Over the weekend, I had the opportunity to attend the JDRF Capitol Chapter’s first annual Research Summit in Bethesda, MD. The summit had a very impressive line-up, including Dan Hurley, author of the book Diabetes Rising, and Dr. Aaron Kowalski, JDRF’s Vice President of Treatment Therapies.
I had the opportunity to speak with Dr. Edward Damiano, a researcher at Boston University who’s currently steeped in multi-day human trials for the control algorithm on the artificial…
Read more »
There were a number of encouraging news announcements this week here in Florida about progress on the JDRF’s Artificial Pancreas Project. The most prominent of those is today’s unveiling of the results of the STAR 3 Trial (Sensor-Augmented Pump Therapy for A1C Reduction) that showed adults, teens and children achieving a 4x reduction in A1C levels using this tech-heavy therapy versus patients on injections.
The STAR study, sponsored by Medtronic, was conducted at 30 clinics…
Read more »
